Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers March 2013

Peter Urbani' Statistics - Monte Carlo may overestimate individual asset risks by up to two thirds

 

Injudicious use of Monte Carlo simulations could overestimate individual asset risks by two thirds if strict normality is assumed and the shape of the underlying distributions is ignored. Similarly total returns and Sharpe Ratios could be overstated by 20% or more when assuming strict normality. Individual assets that have positively skewed distributions may have their returns under estimated by 13% or more.

Most investors and software do not consider the asymmetry of returns and risks when conducting Monte Carlo simulations of future portfolio returns and simply rely on the central limit theorem to assume normality. Whilst the CLT certainly holds, it does so only over the long-term. In the short run, things may be very different indeed.

This month we look at the three main methods of generating correlated random deviates for the purposes of performing Monte Carlo simulations, namely;

  • The Cholesky Method,
  • The Spectral ( SVD ) Method and,
  • The Inverse method

As you may know, Monte Carlo simulations were invented by Stanislaw Ulam and John von Neumann during their work on the Manhattan project. The requirement for significant computing power meant that the method remained the preserve of think tanks, large universities and corporations until around the the 1980s and the advent of the Personal Computer. Since then, the use of the method has exploded and it has become ubiquitous in finance and financial planning even to the detriment of stopping people from trying to find closed form solutions for some problems which may have them.

Thanks to Moore’s law, most of us now have sufficient computing pow......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for